Cargando…
Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
BACKGROUND: Current guidelines do not address the post–sustained virological response management of patients with baseline hepatitis C virus (HCV) cirrhosis and oesophageal varices taking betablockers as primary or secondary prophylaxis of variceal bleeding. We hypothesized that in some of these pat...
Autores principales: | Abadía, Marta, Montes, María Luisa, Ponce, Dolores, Froilán, Consuelo, Romero, Miriam, Poza, Joaquín, Hernández, Teresa, Fernández-Martos, Rubén, Olveira, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558437/ https://www.ncbi.nlm.nih.gov/pubmed/31210717 http://dx.doi.org/10.3748/wjg.v25.i21.2665 |
Ejemplares similares
-
Betablockers for haemodynamically stable acute myocarditis
por: Monti, Lorenzo, et al.
Publicado: (2014) -
Treatment with betablockers is associated with higher grey-scale median in carotid plaques
por: Asciutto, Giuseppe, et al.
Publicado: (2014) -
Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis
por: Zhong, Hao-Jie, et al.
Publicado: (2019) -
Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome
por: Topf, Albert, et al.
Publicado: (2022) -
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)